Floatz logo

CARMUSTINE

Recurrent Adult Hodgkin Lymphoma

VIVUS LLCSmall moleculePhase 2Active
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
95/ 100

Competitive context

149 Active assets in the Recurrent Adult Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Fred Hutchinson Cancer Center
Phase 3BBB
CYCLOSPORIN A
City of Hope Medical Center
Phase 3BBB
METHOTREXATE
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BBB
Cytosin-Arabinosid
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BBB
Everolimus
OHSU Knight Cancer Institute
Phase 2BBB

View all 50 →

Same molecule, other indications

CARMUSTINE is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
74 / 100
View asset →
B-cell non-Hodgkin lymphomaDormant
BBB
Indicative ·
73 / 100
View asset →
central nervous system neoplasmDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →